These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22891258)

  • 1. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study.
    Morton J; Zoungas S; Li Q; Patel AA; Chalmers J; Woodward M; Celermajer DS; Beulens JW; Stolk RP; Glasziou P; Ng MK;
    Diabetes Care; 2012 Nov; 35(11):2201-6. PubMed ID: 22891258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol and the risk of nephropathy in type 2 diabetic patients.
    Chang YH; Chang DM; Lin KC; Hsieh CH; Lee YJ
    Nutr Metab Cardiovasc Dis; 2013 Aug; 23(8):751-7. PubMed ID: 22789808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Eliasson B; Cederholm J; Eeg-Olofsson K; Svensson AM; Zethelius B; Gudbjörnsdottir S;
    Diabetes Care; 2011 Sep; 34(9):2095-100. PubMed ID: 21775750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus.
    Zoppini G; Negri C; Stoico V; Casati S; Pichiri I; Bonora E
    Metabolism; 2012 Jan; 61(1):22-9. PubMed ID: 21676418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
    Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
    Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
    Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
    Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study.
    Tolonen N; Hietala K; Forsblom C; Harjutsalo V; Mäkinen VP; Kytö J; Summanen PA; Thorn LM; Wadén J; Gordin D; Taskinen MR; Groop PH;
    J Intern Med; 2013 Nov; 274(5):469-79. PubMed ID: 23844944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study.
    Rathsman B; Haas J; Persson M; Ludvigsson J; Svensson AM; Lind M; Andersson Franko M; Nyström T
    J Intern Med; 2021 Jun; 289(6):873-886. PubMed ID: 33283333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?
    Drexel H; Aczel S; Marte T; Benzer W; Langer P; Moll W; Saely CH
    Diabetes Care; 2005 Jan; 28(1):101-7. PubMed ID: 15616241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Serum Zinc Level and Microvascular Complications in Patients with Type 2 Diabetes.
    Luo YY; Zhao J; Han XY; Zhou XH; Wu J; Ji LN
    Chin Med J (Engl); 2015 Dec; 128(24):3276-82. PubMed ID: 26668140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
    Welsh P; Rankin N; Li Q; Mark PB; Würtz P; Ala-Korpela M; Marre M; Poulter N; Hamet P; Chalmers J; Woodward M; Sattar N
    Diabetologia; 2018 Jul; 61(7):1581-1591. PubMed ID: 29728717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis.
    Hukportie DN; Li FR; Zhou R; Zheng JZ; Wu XX; Zou MC; Wu XB
    J Diabetes; 2022 Jun; 14(6):365-376. PubMed ID: 35668633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
    Morton J; Ng MK; Chalmers J; Woodward M; Mancia G; Poulter NR; Marre M; Cooper ME; Zoungas S;
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1628-33. PubMed ID: 23780837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.